Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenichiro Arakawa

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Biochimica Et Biophysica Acta|May 24, 2011
In vivo functional brain imaging and a therapeutic trial of L-arginine in MELAS patientsMakoto Yoneda, Masamichi Ikawa, Kenichiro Arakawa, et al.
Mitochondrion|February 7, 2007
Evaluation of respiratory chain failure in mitochondrial cardiomyopathy by assessments of 99mTc-MIBI washout and 123I-BMIPP/99mTc-MIBI mismatchMasamichi Ikawa, Yasuyuki Kawai, Kenichiro Arakawa, et al.
European Neurology|April 21, 2012
Evaluation of systemic redox states in patients carrying the MELAS A3243G mutation in mitochondrial DNAMasamichi Ikawa, Kenichiro Arakawa, Tadanori Hamano, et al.
Mitochondrion|May 23, 2009
PET imaging of redox and energy states in stroke-like episodes of MELASMasamichi Ikawa, Hidehiko Okazawa, Kenichiro Arakawa, et al.
Journal of Hypertension|July 14, 2010
A new-generation N/L-type calcium channel blocker leads to less activation of the renin-angiotensin system compared with conventional L type calcium channel blockerTadashi Konoshita, Yasukazu Makino, Tomoko Kimura, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|November 30, 2013
Effects of combination therapy with olmesartan and azelnidipine on serum osteoprotegerin in patients with hypertensionHiroyasu Uzui, Tetsuji Morishita, Akira Nakano, et al.
Cell Biochemistry and Function|February 3, 2011
First survey of the three gene polymorphisms (PON1 Q192R, eNOS E298D and eNOS C-786T) potentially associated with coronary artery spasm in African populations and comparison with worldwide dataJunko Fujihara, Toshihiro Yasuda, Yasuyuki Kawai, et al.
Kekkaku : [Tuberculosis]|July 26, 2002
[A case of cutaneous tuberculosis under steroid & immunosuppressant therapy for dermatomyositis]Masakuni Fujita, Kenichiro Arakawa, Shiro Mizuno, et al.
International Journal of Cardiology|November 25, 2011
A crossover comparison of urinary albumin excretion as a new surrogate marker for cardiovascular disease among 4 types of calcium channel blockersTadashi Konoshita, Yasukazu Makino, Tomoko Kimura, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 3, 2008
Synergy of aldosterone and high salt induces vascular smooth muscle hypertrophy through up-regulation of NOX1Chunyuan Fan, Yasuyuki Kawai, Satoru Inaba, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Biochimica Et Biophysica Acta|May 24, 2011
In vivo functional brain imaging and a therapeutic trial of L-arginine in MELAS patientsMakoto Yoneda, Masamichi Ikawa, Kenichiro Arakawa, et al.
Mitochondrion|February 7, 2007
Evaluation of respiratory chain failure in mitochondrial cardiomyopathy by assessments of 99mTc-MIBI washout and 123I-BMIPP/99mTc-MIBI mismatchMasamichi Ikawa, Yasuyuki Kawai, Kenichiro Arakawa, et al.
European Neurology|April 21, 2012
Evaluation of systemic redox states in patients carrying the MELAS A3243G mutation in mitochondrial DNAMasamichi Ikawa, Kenichiro Arakawa, Tadanori Hamano, et al.
Mitochondrion|May 23, 2009
PET imaging of redox and energy states in stroke-like episodes of MELASMasamichi Ikawa, Hidehiko Okazawa, Kenichiro Arakawa, et al.
Journal of Hypertension|July 14, 2010
A new-generation N/L-type calcium channel blocker leads to less activation of the renin-angiotensin system compared with conventional L type calcium channel blockerTadashi Konoshita, Yasukazu Makino, Tomoko Kimura, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|November 30, 2013
Effects of combination therapy with olmesartan and azelnidipine on serum osteoprotegerin in patients with hypertensionHiroyasu Uzui, Tetsuji Morishita, Akira Nakano, et al.
Cell Biochemistry and Function|February 3, 2011
First survey of the three gene polymorphisms (PON1 Q192R, eNOS E298D and eNOS C-786T) potentially associated with coronary artery spasm in African populations and comparison with worldwide dataJunko Fujihara, Toshihiro Yasuda, Yasuyuki Kawai, et al.
Kekkaku : [Tuberculosis]|July 26, 2002
[A case of cutaneous tuberculosis under steroid & immunosuppressant therapy for dermatomyositis]Masakuni Fujita, Kenichiro Arakawa, Shiro Mizuno, et al.
International Journal of Cardiology|November 25, 2011
A crossover comparison of urinary albumin excretion as a new surrogate marker for cardiovascular disease among 4 types of calcium channel blockersTadashi Konoshita, Yasukazu Makino, Tomoko Kimura, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 3, 2008
Synergy of aldosterone and high salt induces vascular smooth muscle hypertrophy through up-regulation of NOX1Chunyuan Fan, Yasuyuki Kawai, Satoru Inaba, et al.
Pageof 3